We are live on ! Find out more
UOC

UBS O'Connor Portfolio holdings

AUM $3.38B
1-Year Est. Return 63.08%
This Fund
S&P 500
This Quarter Est. Return
+9.09%
1 Year Est. Return
+63.08%
3 Year Est. Return
+180.99%
5 Year Est. Return
+483.22%
10 Year Est. Return
+2,128.62%
AUM
$5.62B
AUM Growth
+$874M
Cap. Flow
+$536M
Cap. Flow %
9.53%
Top 10 Hldgs %
66.07%
Holding
710
New
128
Increased
146
Reduced
103
Closed
149

Top Buys

Rank Stock Value
1
ATVI
Activision Blizzard
ATVI
+$779M
2
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
+$358M
3
NEWR
New Relic, Inc.
NEWR
+$258M
4
DEN
Denbury Inc.
DEN
+$175M
5
VMW
VMware, Inc
VMW
+$165M

Top Sells

Rank Stock Value
1
ISEE
IVERIC bio, Inc. Common Stock
ISEE
+$230M
2
PDCE
PDC Energy, Inc.
PDCE
+$221M
3
UNVR
Univar Solutions Inc.
UNVR
+$219M
4
FOCS
Focus Financial Partners Inc. Class A
FOCS
+$146M
5
SYNH
Syneos Health, Inc. Class A Common Stock
SYNH
+$141M

Sector Composition

Rank Sector Weight
1 Technology 34.82%
2 Healthcare 28.77%
3 Real Estate 5.15%
4 Financials 4.39%
5 Consumer Discretionary 4.35%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
LYFT icon
451
Lyft
LYFT
$6.44B
$105K ﹤0.01%
+10,000
New +$111K
IWM icon
452
CALL
iShares Russell 2000 ETF
IWM
$82.9B
$97.6K ﹤0.01%
40,000
+10,000
+33% +$1.88M
GDX icon
453
CALL
VanEck Gold Miners ETF
GDX
$27.4B
$97.5K ﹤0.01%
+500,000
New +$14.7M
CZR icon
454
PUT
Caesars Entertainment
CZR
$6.13B
$93.8K ﹤0.01%
+15,000
New +$797K
APLS
455
PUT
DELISTED
Apellis Pharmaceuticals
APLS
$91.5K ﹤0.01%
+15,000
New +$659K
XAGEW
456
DELISTED
Longevity Health Holdings, Inc. Warrant
XAGEW
$91K ﹤0.01%
+371,250
New +$91.8K
SVC
457
PUT
Service Properties Trust
SVC
$1.1B
$80.5K ﹤0.01%
29,260
– –
XBI icon
458
CALL
State Street SPDR S&P Biotech ETF
XBI
$10.2B
$76.1K ﹤0.01%
+75,000
New +$5.99M
EXPE icon
459
PUT
Expedia Group
EXPE
$37.3B
$68.2K ﹤0.01%
11,000
– –
MRTX
460
CALL
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
$66.9K ﹤0.01%
25,000
– –
WDC icon
461
PUT
Western Digital
WDC
$149B
$63.4K ﹤0.01%
19,184
– –
KPTI icon
462
CALL
Karyopharm Therapeutics
KPTI
$45.1M
$60K ﹤0.01%
+20,000
New +$449K
CONXW
463
DELISTED
CONX Corp. Warrant
CONXW
$57.5K ﹤0.01%
460,218
– –
UAL icon
464
PUT
United Airlines
UAL
$41.7B
$57.3K ﹤0.01%
333,900
– –
CVIIW
465
DELISTED
Churchill Capital Corp VII Warrants
CVIIW
$55.9K ﹤0.01%
193,548
– –
DAL icon
466
PUT
Delta Air Lines
DAL
$60.2B
$55.5K ﹤0.01%
27,900
– –
VICI icon
467
PUT
VICI Properties
VICI
$29.3B
$55.4K ﹤0.01%
32,100
– –
GRTX
468
DELISTED
Galera Therapeutics, Inc. Common Stock
GRTX
$52.9K ﹤0.01%
302,506
-268,000
-47% -$333K
RCUS icon
469
CALL
Arcus Biosciences
RCUS
$3.61B
$52.5K ﹤0.01%
+35,000
New +$703K
BCYC
470
CALL
Bicycle Therapeutics
BCYC
$290M
$52.3K ﹤0.01%
+23,500
New +$537K
RYTM icon
471
CALL
Rhythm Pharmaceuticals
RYTM
$7.82B
$49.5K ﹤0.01%
+45,000
New +$1.01M
NAVI icon
472
PUT
Navient
NAVI
$849M
$48.8K ﹤0.01%
37,500
-22,500
-38% -$405K
ARVN icon
473
CALL
Arvinas
ARVN
$570M
$48K ﹤0.01%
+60,000
New +$1.47M
BPMC
474
CALL
DELISTED
Blueprint Medicines
BPMC
$47.9K ﹤0.01%
+25,000
New +$1.34M
INCY icon
475
CALL
Incyte
INCY
$24.4B
$47.3K ﹤0.01%
+70,000
New +$4.41M
17 18
19
20 21

Similar funds

FNBT
FineMark National Bank & Trust Fort Myers, Florida $3.2B AUM 18.28% 1-Year Est. Return
SAG
SageView Advisory Group Newport Beach, California $2.96B AUM 15.81% 1-Year Est. Return
ACI
Alpha Cubed Investments Irvine, California $2.92B AUM 31.27% 1-Year Est. Return
TCOV
Trust Company of Vermont Brattleboro, Vermont $2.4B AUM 18.8% 1-Year Est. Return
RC
RGM Capital Naples, Florida $2.06B AUM 8.49% 1-Year Est. Return
A
AlphaQuest New York $1.79B AUM 10.61% 1-Year Est. Return
CGL
Clarius Group LLC Seattle, Washington $1.75B AUM 19.04% 1-Year Est. Return
CB
Cadence Bank Tupelo, Mississippi $1.71B AUM 16.17% 1-Year Est. Return

UBS O'Connor's Q3 2023 Portfolio in Review

As of Q3 2023, UBS O'Connor held 710 positions worth $5.62B, up 18% from $4.75B the previous quarter. Its ten largest holdings account for 66% of the portfolio.

UBS O'Connor deployed $536M of net new capital in Q3 2023, opening 128 new positions and adding to 146 existing holdings. Its largest new stake was Denbury Inc.: 1,931,731 shares worth $189M.

By sector, the portfolio is most concentrated in Technology at 35% of assets, up from 16% a quarter earlier, followed by Healthcare and Real Estate.

On the sell side, the largest reduction was Seagen Inc. Common Stock, an estimated $19.7M trimmed.

  • UBS O'Connor's largest Q3 2023 buy was Denbury Inc.: 1,931,731 shares worth $189M.
  • UBS O'Connor added most to Activision Blizzard in Q3 2023, an estimated $779M increase.
  • UBS O'Connor's biggest Q3 2023 reduction was Seagen Inc. Common Stock, cutting an estimated $19.7M.
  • UBS O'Connor fully exited IVERIC bio, Inc. Common Stock in Q3 2023, selling an estimated $230M.
  • UBS O'Connor's ten largest holdings make up 66% of its $5.62B portfolio in Q3 2023.
  • UBS O'Connor opened 128 new positions and closed 149 in Q3 2023.
  • UBS O'Connor's portfolio value rose 18% quarter-over-quarter to $5.62B.

Based on UBS O'Connor's 13F filing for Q3 2023, filed 14 Nov 2023.